Home News Company news...
October 03, 2024

A Lifesaving Mission: MEBO‘s Swift Aid in Thai Bus Fire Tragedy Strengthens China-Thailand Ties

On October 1, 2024, a devastating school bus fire near Bangkok claimed the lives of 25 students, leaving 20 others with severe injuries. In response to this tragic event, the Thai government promptly sought assistance from the Chinese Embassy, requesting MEBO Moist Exposed Burn Ointment to aid burn treatment. Within just 15 hours, MEBO's burn ointment was on the ground in Bangkok, delivering essential medical relief to those impacted.

Symbolic Handover Ceremony Highlights International Cooperation

On October 2, an official handover occurred at Don Mueang International Airport. During the ceremony, Minister Wu Zhiwu, representing Chinese Ambassador Han Zhiqiang, formally presented the MEBO ointment to Thai Health Minister Somsak and Justice Minister Tawi. This occasion underscored the strong bond between China and Thailand, symbolizing mutual support and gratitude during challenging times.

 

MEBO's Legacy of Medical Collaboration with Thailand

Since 1990, MEBO has been a significant player in Sino-Thai medical cooperation. Its partnership began when Dr. Rongxiang Xu, MEBO's founder, treated over 200 burn victims following a gas tanker explosion in Bangkok. This initial collaboration marked the start of an enduring relationship, with MEBO continuing to work closely with Thai hospitals to advance burn treatment capabilities.

 

Strengthening China-Thailand Relations Through Timely Support

MEBO's rapid response provided lifesaving treatment and highlighted the enduring friendship between China and Thailand. This swift medical support underscores Thailand's trust in MEBO's expertise and reinforces the cooperative ties between the two nations. As MEBO stands with Thailand, we extend our deepest wishes for the recovery of all affected.

 


 

About MEBO

Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.

At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.

As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.